Sign in
CompletedNo phase

Follow-up of Covid-19 Long Term Sequelae

Key facts

Who runs it
Azienda Ospedaliera Universitaria Integrata Verona
Where
Belgium, Congo - Brazzaville, France, Italy, Netherlands, and Spain7 sites in 6 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
7,599 people enrolled
Started
16 Apr 2021
Ended
31 May 2024
Type of study
Observational
Treatments tested
  • Not applicable (observational study)
Record updated
28 October 2024

Who can take part

Age
14 years and older
Sex
Women and men

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Any comorbidity
  • Laboratory confirmed SARS-CoV-2 infection by PCR diagnosis from nasopharynx, oropharynx, bronchoalveolar lavage, stool, or blood. Rapid tests are an acceptable alternative
  • Individuals (or attorney or deputy who has been authorized to make the decision for patients who lack capacity) consent to participate
  • Individuals over 14 years of ages

Who cannot take part

  • Lack of laboratory confirmed SARS-CoV-2 infection
  • Individuals under 14 years of ages
  • Lack of consent to participate

Where is this trial?

It has sites in 6 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The protocol, in accordance with the objectives of ORCHESTRA project - Work Package 2, aims at investigating the characteristics and determinants of COVID-19 long-term sequelae. This goal will be reached through the harmonization of follow-up strategies across the participating cohorts to allow a standardized collection of data on COVID-19 long-term sequelae. The result will be a platform including a set of data and biomaterials from large scale international cohorts, that will be uniformly recorded, prospectively tracked and analysed. The ultimate goal will be that of providing evidence to contribute to the optimization and improvement of the management and prevention of COVID-19 sequelae.

Read full original descriptionShow less

The follow-up will be organized in multiple levels of tests, according to the capability of each cohort, and will include questionnaires to collect demographic, epidemiological and clinical data, physical examination, radiological exams and biological sampling. The long-term follow-up will also allow the assessment of long-term immunological response to SARS-CoV-2 infection and its association to the vaccination and to different treatment strategies, including monoclonal antibodies.

Treatments tested

  • Not applicable (observational study)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
ORCHESTRA WP2 - Follow-up of Covid-19 Long Term Sequelae
Publications
Record updated
28 October 2024